Results 71 to 80 of about 1,279 (113)

[Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis]. [PDF]

open access: yesRev Neurol, 2022
García-Estévez DA   +4 more
europepmc   +1 more source

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study

open access: yesFrontiers in Immunology
IntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the ...
Berenice Anabel Silva   +38 more
doaj   +1 more source

[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]

open access: yesRev Neurol, 2022
Lafuente-Gómez G   +11 more
europepmc   +1 more source

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2

open access: yesNeurología, 2020
G. Álvarez Bravo, L. Ramió i Torrentà
doaj   +1 more source

Impact of the COVID-19 pandemic on the physical activity habits of people with multiple sclerosis in Spain

open access: yesNeurology Perspectives
Background: According to the literature, patients with multiple sclerosis (MS) are less active and show higher levels of sedentary behaviour than the general population of the same age range. This study aims to explore the impact of the COVID-19 pandemic
C. Santoyo-Medina   +12 more
doaj   +1 more source

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. [PDF]

open access: yesNeurologia (Engl Ed), 2021
Piñar Morales R   +2 more
europepmc   +1 more source

Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America. [PDF]

open access: yesArq Neuropsiquiatr, 2021
Rojas JI   +15 more
europepmc   +1 more source

Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis. [PDF]

open access: yesRev Bras Enferm, 2022
Brandão PMF   +5 more
europepmc   +1 more source

Erratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357–362]

open access: yesNeurología (English Edition), 2020
G. Valero-López   +10 more
doaj   +1 more source

Content, educational value and quality analysis of videos about neurorehabilitation in people with multiple sclerosis on YouTube®. [PDF]

open access: yesRev Neurol
Cano-de-la-Cuerda R   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy